Macromoltek

We design antibodies computationally for difficult targets

• Macromoltek Announces Computational De Novo Antibody Design Offering, Targeting COVID-19

  prnewswire.com

  /PRNewswire/ -- Macromoltek, Inc. today announced computational de novo design capability to speed up the development of human monoclonal antibodies for the...

• Macromoltek Announces Computational De Novo Antibody Design Offering, Targeting COVID-19

  www.prnewswire.com

  /PRNewswire/ -- Macromoltek, Inc. today announced computational de novo design capability to speed up the development of human monoclonal antibodies for the...

• Macromoltek Deploys Computational Design Platform To Enable Cytovia Therapeutics Drug Development For COVID-19

  www.prnewswire.com

  /PRNewswire/ -- Macromoltek, Inc. today announced the application of its computational design technology for their recently disclosed partnership with Cytovia...